GB ACT, INC.
1Patents
1Active
1Granted
37Portfolio score
Filing activity: May 9, 2017 → May 9, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10010542B2 | PFKFB3 inhibit and methods of use as an anti-cancer therapeutic | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.